A Safety and Efficacy Study for Infliximab (Remicade) in Patients With Active Ulcerative Colitis

Clinical trial NCT00036439 · COMPLETED

Trial details

NCT number: NCT00036439
Sponsor: Centocor, Inc.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Ulcerative Colitis

Start date: 2002-02-01
Enrollment: 364

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.